¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ

Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast cancer in men and women, and in ovarian cancer. Now BRCA1 and BRCA2 have been linked to several other cancers, including those that affect men.

An international team of scientists, led by researchers based at the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Research Institute, have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment, germcitabine.